Category INDUSTRY UPDATES

Element Biosciences Upsizes Series E to Accelerate Global Expansion in Genomics and Multiomics

Element Biosciences Raises Upsized Series E to Accelerate Global Expansion Across Genomic, Multiomic, and Clinical Research Solutions Ecosystem Element Biosciences has announced an upsized Series E financing round, anchored by a $175 million investment from long-standing strategic backer Samsung Electronics,…

Read MoreElement Biosciences Upsizes Series E to Accelerate Global Expansion in Genomics and Multiomics

Seek Labs Maps 25 Viral Families via BioSeeker, Advancing Sequence-Directed Antiviral Discovery Model

Seek Labs Maps 25 Viral Families with BioSeeker, Advancing a Sequence-Driven Model for Antiviral Discovery Seek Labs, a private TechBio company focused on developing programmable platforms to decode, program, and ultimately resolve disease mechanisms, has announced a major scientific milestone…

Read MoreSeek Labs Maps 25 Viral Families via BioSeeker, Advancing Sequence-Directed Antiviral Discovery Model

Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference

Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced new clinical and long-term follow-up data highlighting the expanding impact of its cystic fibrosis (CF) treatment portfolio, particularly ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), across very…

Read MoreVertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference

Teva Presents Real-World Reported Benefits of AUSTEDO® and AUSTEDO XR® in Huntington’s Disease Chorea

Teva Presents New AUSTEDO® and AUSTEDO XR® Data Showing Patient- and Caregiver-Reported Improvements in Huntington’s Disease Chorea Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has announced new real-world evidence demonstrating that treatment with…

Read MoreTeva Presents Real-World Reported Benefits of AUSTEDO® and AUSTEDO XR® in Huntington’s Disease Chorea

Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award

Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award John M. Kane, MD, a leading figure in schizophrenia research and co-director of the Institute of Behavioral Science at Northwell Health’s Feinstein Institutes for Medical Research,…

Read MoreFeinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award

Glooko Launches First EHR Integration for Insulin Pump Data Integration into Clinical Workflows

Glooko Launches First-Ever Insulin Pump Settings EHR Integration to Streamline Clinical Workflows and Data Access Glooko, Inc., a global digital health company focused on improving diabetes management and supporting clinicians in addressing glycemic safety across the full continuum of care,…

Read MoreGlooko Launches First EHR Integration for Insulin Pump Data Integration into Clinical Workflows

VB Spine Funds Research to Develop First Predictive Blood Test for Adolescent Scoliosis

VB Spine Partners to Fund Breakthrough Pediatric Scoliosis Genetics Research Led by Dr. Alain Moreau VB Spine LLC, a global, family-owned spine-focused medical company, has announced a strategic partnership to fund advanced research into the molecular genetics of pediatric scoliosis.…

Read MoreVB Spine Funds Research to Develop First Predictive Blood Test for Adolescent Scoliosis